Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Atherosclerosis|October 1, 2013
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonistRebecca Taub, Edward Chiang, Malorie Chabot-Blanchet, et al.American Journal of Physiology. Gastrointestinal and Liver Physiology|November 8, 2014
Protein tyrosine phosphatase of liver regeneration-1 is required for normal timing of cell cycle progression during liver regenerationYang Jiao, Diana Z Ye, Zhaoyu Li, et al.Gastro Hep Advances|October 27, 2025
The Cholate Challenge Test Quantified Baseline Functional Heterogeneity and Improvement in Response to Resmetirom in MASH-related Child-Pugh A CirrhosisNaim Alkhouri, Michael P McRae, Rebecca Taub, et al.The Biochemical Journal|March 29, 2008
Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescenceBogumil Zelent, Stella Odili, Carol Buettger, et al.Nature Medicine|October 16, 2023
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trialStephen A Harrison, Rebecca Taub, Guy W Neff, et al.European Journal of Pharmacology|March 22, 2005
Disconnection between the early onset anorectic effects by C75 and hypothalamic fatty acid synthase inhibition in rodentsKenneth W Rohrbach, Songping Han, Jinping Gan, et al.The Journal of Biological Chemistry|March 6, 2003
Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorptionDong Cheng, Thomas C Nelson, Jian Chen, et al.Diabetes|April 2, 2009
Extremes of clinical and enzymatic phenotypes in children with hyperinsulinism caused by glucokinase activating mutationsSamir Sayed, David R Langdon, Stella Odili, et al.Bioorganic & Medicinal Chemistry Letters|October 18, 2011
Discovery and optimization of 2-phenyloxazole derivatives as diacylglycerol acyltransferase-1 inhibitorsWeiya Yun, Mushtaq Ahmad, Yingsi Chen, et al.The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Receptor occupancy of nonpeptide corticotropin-releasing factor 1 antagonist DMP696: correlation with drug exposure and anxiolytic efficacyYu-Wen Li, Geraldine Hill, Harvey Wong, et al.Pageof 5